One mouse, one patient paradigm: New avatars of personalized cancer therapy P Malaney, SV Nicosia, V Davé Cancer letters 344 (1), 1-12, 2014 | 351 | 2014 |
Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases VN Uversky, V Davé, LM Iakoucheva, P Malaney, SJ Metallo, RR Pathak, ... Chemical reviews 114 (13), 6844-6879, 2014 | 286 | 2014 |
PTEN proteoforms in biology and disease P Malaney, VN Uversky, V Davé Cellular and Molecular Life Sciences 74, 2783-2794, 2017 | 88 | 2017 |
Intrinsic disorder in PTEN and its interactome confers structural plasticity and functional versatility P Malaney, RR Pathak, B Xue, VN Uversky, V Davé Scientific reports 3 (1), 2035, 2013 | 86 | 2013 |
A unified nomenclature and amino acid numbering for human PTEN R Pulido, SJ Baker, JT Barata, A Carracedo, VJ Cid, ID Chin-Sang, ... Science signaling 7 (332), pe15-pe15, 2014 | 68 | 2014 |
The PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapy P Malaney, VN Uversky, V Davé Molecular Biosystems 9 (11), 2877-2888, 2013 | 57 | 2013 |
PTEN physically interacts with and regulates E2F1-mediated transcription in lung cancer P Malaney, E Palumbo, J Semidey-Hurtado, J Hardee, K Stanford, ... Cell Cycle 17 (8), 947-962, 2018 | 43 | 2018 |
Uncovering the role of RNA-binding protein hnRNP K in B-cell lymphomas M Gallardo, P Malaney, MJL Aitken, X Zhang, TM Link, V Shah, ... JNCI: Journal of the National Cancer Institute 112 (1), 95-106, 2020 | 26 | 2020 |
Loss of phosphatase and tensin homolog (PTEN) induces leptin-mediated leptin gene expression: feed-forward loop operating in the lung RR Pathak, A Grover, P Malaney, W Quarni, A Pandit, D Allen-Gipson, ... Journal of Biological Chemistry 288 (41), 29821-29835, 2013 | 21 | 2013 |
Identification of intrinsically disordered regions in PTEN and delineation of its function via a network approach P Malaney, VN Uversky, V Davé Methods 77, 69-74, 2015 | 20 | 2015 |
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill F LT 3-ITD acute myeloid leukemia SM Post, H Ma, P Malaney, X Zhang, MJL Aitken, PY Mak, VR Ruvolo, ... Haematologica 107 (6), 1311, 2022 | 14 | 2022 |
Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered Runx1 splicing MJL Aitken, P Malaney, X Zhang, SM Herbrich, L Chan, O Benitez, ... NAR cancer 4 (4), zcac039, 2022 | 5 | 2022 |
Assessing the role of intrinsic disorder in RNA-binding protein function: hnRNP K as a case study P Malaney, O Benitez, X Zhang, SM Post Methods 208, 59-65, 2022 | 3 | 2022 |
The Eµ-hnRNP K murine model of lymphoma: novel insights into the role of hnRNP K in B-cell malignancies P Malaney, M Velasco-Estevez, P Aguilar-Garrido, MJL Aitken, LE Chan, ... Frontiers in immunology 12, 634584, 2021 | 3 | 2021 |
Combination Therapy with BTK Inhibitor Plus Anti-PD-1 Antibody Results in a Hyperprogressor Phenotype in a Mouse Model of CLL A Gu, H Ma, X Zhang, P Malaney, M Gallardo, J Liu, SS Neelapu, SM Post Blood 132, 4416, 2018 | 3 | 2018 |
Insight into the mechanism of AML del (9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU. 1) K Rahn, AT Abdallah, L Gan, S Herbrich, R Sonntag, O Benitez, ... Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1867 (1), 195004, 2024 | 2 | 2024 |
hnRNPK as a Driver of Lymphomagenesis P Malaney, M Hornbaker, M Gallardo, X Zhang, M McArthur, ... Clinical Lymphoma, Myeloma and Leukemia 17, S374-S375, 2017 | 2 | 2017 |
Creating accessibility in academic negotiations JH Kong, CG Vasquez, S Agrawal, P Malaney, MM Mikedis, AB Moffitt, ... Trends in Biochemical Sciences 48 (3), 203-210, 2023 | 1 | 2023 |
Adar1 deletion causes degeneration of the exocrine pancreas via Mavs-dependent interferon signaling DN Rupani, FI Thege, V Chandra, H Rajaei, RW Cowan, SM Wörmann, ... Development 150 (2), dev201097, 2023 | 1 | 2023 |
S104: RBPs dysregulation cause hyper-nucleoli and ribosome gain-of-function driving bone marrow failure P Aguilar-Garrido, M Velasco, MH Sánchez, MÁN Aguadero, P Malaney, ... HemaSphere 6, 5-6, 2022 | 1 | 2022 |